101 Therapeutics
Developing Cures for Multiple Infectious Diseases
Active
Seed
Startup
Tel Aviv-Yafo
Founded 2020-11
101 Therapeutics has developed the first-ever targeted glucocorticoid with all of the potency of steroids and none of the systemic toxicities. By targeting the host immune system rather than the pathogen itself, the company can effectively treat a multitude of infectious diseases, whether viral, parasitic, or bacterial.
SectorHealth Tech & Life Sciences
StageSeed
Employees3
Founded2020-11
HQTel Aviv-Yafo
Confidence89
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals